Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Harada

Showing results (251-260 of 283) with videos related to

Pageof 29
Sort By:
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|July 13, 2017
H<sub>2</sub>Mab-77 is a Sensitive and Specific Anti-HER2 Monoclonal Antibody Against Breast CancerShunsuke Itai, Yuki Fujii, Mika K Kaneko, et al.
Laryngoscope Investigative Otolaryngology|September 7, 2018
Detection of Second Primary Malignancies of the Esophagus and Hypophraynx in Oral Squamous Cell Carcinoma PatientsToshihiro Matsui, Takuya Okada, Kenro Kawada, et al.
Oncotarget|June 2, 2018
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinomaShunsuke Itai, Tomokazu Ohishi, Mika K Kaneko, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|November 21, 2018
Anti-Bovine Podoplanin Monoclonal Antibody PMab-44 Detects Goat Podoplanin in ImmunohistochemistryShinji Yamada, Mika K Kaneko, Yoshikazu Furusawa, et al.
Journal of Dental Sciences|July 22, 2024
Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in JapanMitsunobu Otsuru, Nobuhiro Yamakawa, Tadaaki Kirita, et al.
BMC Oral Health|January 27, 2022
Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective studyYasuyuki Michi, Hiroyuki Harada, Yu Oikawa, et al.
Frontiers in Oncology|October 30, 2023
Invasion of the bucco-mandibular space by oral squamous cell carcinoma: histopathological analysis of invasion patternTakuma Kugimoto, Naoto Nishii, Yu Oikawa, et al.
Auris, Nasus, Larynx|March 2, 2022
Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neckShuya Otsuki, Ryusuke Hori, Shogo Shinohara, et al.
Cancers|September 11, 2019
Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck CarcinomaRyusuke Hori, Shogo Shinohara, Tsuyoshi Kojima, et al.
The Journal of Toxicological Sciences|March 16, 2018
Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadineKentaro Ando, Yuji Nakamura, Mihoko Hagiwara-Nagasawa, et al.
Pageof 29

Showing results (251-260 of 283) with videos related to

Sort By:
Pageof 29
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|July 13, 2017
H<sub>2</sub>Mab-77 is a Sensitive and Specific Anti-HER2 Monoclonal Antibody Against Breast CancerShunsuke Itai, Yuki Fujii, Mika K Kaneko, et al.
Laryngoscope Investigative Otolaryngology|September 7, 2018
Detection of Second Primary Malignancies of the Esophagus and Hypophraynx in Oral Squamous Cell Carcinoma PatientsToshihiro Matsui, Takuya Okada, Kenro Kawada, et al.
Oncotarget|June 2, 2018
Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinomaShunsuke Itai, Tomokazu Ohishi, Mika K Kaneko, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|November 21, 2018
Anti-Bovine Podoplanin Monoclonal Antibody PMab-44 Detects Goat Podoplanin in ImmunohistochemistryShinji Yamada, Mika K Kaneko, Yoshikazu Furusawa, et al.
Journal of Dental Sciences|July 22, 2024
Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in JapanMitsunobu Otsuru, Nobuhiro Yamakawa, Tadaaki Kirita, et al.
BMC Oral Health|January 27, 2022
Clinical manifestations of diffuse large B-cell lymphoma that exhibits initial symptoms in the maxilla and mandible: a single-center retrospective studyYasuyuki Michi, Hiroyuki Harada, Yu Oikawa, et al.
Frontiers in Oncology|October 30, 2023
Invasion of the bucco-mandibular space by oral squamous cell carcinoma: histopathological analysis of invasion patternTakuma Kugimoto, Naoto Nishii, Yu Oikawa, et al.
Auris, Nasus, Larynx|March 2, 2022
Real-world 2-year long-term outcomes and prognostic factors in patients receiving nivolumab therapy for recurrent or metastatic squamous cell carcinoma of the head and neckShuya Otsuki, Ryusuke Hori, Shogo Shinohara, et al.
Cancers|September 11, 2019
Real-World Outcomes and Prognostic Factors in Patients Receiving Nivolumab Therapy for Recurrent or Metastatic Head and Neck CarcinomaRyusuke Hori, Shogo Shinohara, Tsuyoshi Kojima, et al.
The Journal of Toxicological Sciences|March 16, 2018
Comparison of electropharmacological effects between terfenadine and its active derivative fexofenadine using a cross-over study in halothane-anesthetized dogs to analyze variability of pharmacodynamic and pharmacokinetic profiles of terfenadine and torsadogenic risk of fexofenadineKentaro Ando, Yuji Nakamura, Mihoko Hagiwara-Nagasawa, et al.
Pageof 29